Logo

Komen Foundation

Guardant Health, Susan G. Komen Partner to Evaluate MRD Test in Breast Cancer

The test is designed to detect circulating tumor DNA in early-stage cancer patients after surgery to help oncologists identify those with residual or recurring disease.

Susan G. Komen Awards $375K to Metastatic Breast Cancer Project

The funding from Susan G. Komen will help support the project's effort to  gather genomic and other data from young breast cancer patients.

Pathway Genomics, Susan G. Komen Partner on Breast Cancer Screening

NEW YORK (GenomeWeb News) – Pathway Genomics and Susan G. Komen today said they are partnering to educate women about screening options available for detecting a genetic predisposition for breast cancer.

WUSTL, ICR to Use $4M Komen Grant to Develop Breast Cancer Dx, Screen Treatments

NEW YORK (GenomeWeb News) – Scientists at Washington University in St. Louis and the Institute of Cancer Research in London plan to use a $4 million grant from the Susan G.

MSU Lands Komen Funding for Tumor Gene Studies

By Matt Jones NEW YORK (GenomeWeb News) – Michigan State University has won a $450,000 grant from the Susan G. Komen for the Cure foundation to conduct studies focused on gene expression in breast cancer tumors.